A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients

Clinical trial NCT02253264 · COMPLETED

Trial details

NCT number: NCT02253264
Sponsor: Johns Hopkins University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Progressive Multiple Sclerosis Secondary Progressive Multiple Sclerosis

Start date: 2014-11-01
Primary completion: 2017-08-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.